aprimeo diagnostics GmbH & Co. KG, a R-Biopharm AG company, starts distribution of the new innovative molecular diagnostics platform Vivalytic from Bosch
Adalimumab (ADM) revolutionized the treatment of patients with inflammatory bowel diseases. Despite its therapeutic success, up to 40 % of patients do not respond to adalimumab induction [...]
Few preventive tests are as effective as colon cancer screening. With early detection, many cases of colon cancer can be cured or even prevented – and modern stool tests make that much easier.